Evidence map›Paper›PMID 37563143›Full record

ArticleNature communications2023

Extravillous trophoblast cell lineage development is associated with active remodeling of the chromatin landscape.

Kaela M Varberg, Esteban M Dominguez, Boryana Koseva, Joseph M Varberg, Ross P McNally, Ayelen Moreno-Irusta, Emily R Wesley, Khursheed Iqbal, Warren A Cheung, Carl Schwendinger-Schreck and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. CHD8-Dependent Chromatin Licensing Sustains Trophoblast Stem Cell Transcriptional Programs.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Directed differentiation of bovine trophoblast stem cells: A useful in vitro model for placenta development.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  13. Article
  14. Current approaches and advances in placental toxicology.Trends in endocrinology and metabolism: TEM · 2026
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Kaela M Varberg *Institute for Reproductive and Developmental Sciences, University of Kansas Medical Center, Kansas City, Kansas, 66160, USA. kvarberg@kumc.edu.ORCID http://orcid.org/0000-0001-9672-4158
Esteban M Dominguez *Institute for Reproductive and Developmental Sciences, University of Kansas Medical Center, Kansas City, Kansas, 66160, USA.
Boryana KosevaGenomic Medicine Center, Children's Mercy Research Institute, Children's Mercy Kansas City, Kansas City, MO, 64108, USA.
Joseph M VarbergStowers Institute for Medical Research, Kansas City, MO, 64110, USA.ORCID http://orcid.org/0000-0002-5235-5896
Ross P McNallyInstitute for Reproductive and Developmental Sciences, University of Kansas Medical Center, Kansas City, Kansas, 66160, USA.ORCID http://orcid.org/0000-0002-9244-8683
Ayelen Moreno-IrustaInstitute for Reproductive and Developmental Sciences, University of Kansas Medical Center, Kansas City, Kansas, 66160, USA.ORCID http://orcid.org/0000-0001-6810-6475
Emily R WesleyGenomic Medicine Center, Children's Mercy Research Institute, Children's Mercy Kansas City, Kansas City, MO, 64108, USA.
Khursheed IqbalInstitute for Reproductive and Developmental Sciences, University of Kansas Medical Center, Kansas City, Kansas, 66160, USA.ORCID http://orcid.org/0000-0002-6742-4591
Warren A CheungGenomic Medicine Center, Children's Mercy Research Institute, Children's Mercy Kansas City, Kansas City, MO, 64108, USA.ORCID http://orcid.org/0000-0003-0267-7464
Carl Schwendinger-SchreckGenomic Medicine Center, Children's Mercy Research Institute, Children's Mercy Kansas City, Kansas City, MO, 64108, USA.
Craig SmailGenomic Medicine Center, Children's Mercy Research Institute, Children's Mercy Kansas City, Kansas City, MO, 64108, USA.
Hiroaki OkaeDepartment of Informative Genetics, Environment and Genome Research Center, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
Takahiro ArimaDepartment of Informative Genetics, Environment and Genome Research Center, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.ORCID http://orcid.org/0000-0001-8094-5167
Michael LydicDepartment of Obstetrics and Gynecology, University of Kansas Medical Center, Kansas City, KS, 66160, USA.
Kristin HolochDepartment of Obstetrics and Gynecology, University of Kansas Medical Center, Kansas City, KS, 66160, USA.
Courtney MarshInstitute for Reproductive and Developmental Sciences, University of Kansas Medical Center, Kansas City, Kansas, 66160, USA.
Michael J SoaresInstitute for Reproductive and Developmental Sciences, University of Kansas Medical Center, Kansas City, Kansas, 66160, USA. msoares@kumc.edu.ORCID http://orcid.org/0000-0001-7158-1592
Elin GrundbergInstitute for Reproductive and Developmental Sciences, University of Kansas Medical Center, Kansas City, Kansas, 66160, USA. egrundberg@cmh.edu.ORCID http://orcid.org/0000-0001-5415-7896
University of Kansas Medical Center · USMercy Research · USTohoku University · JPNorthwestern University · USStowers Institute for Medical Research · US

Funding

TROPHOBLAST DIFFERENTIATIONR01HD020676 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI MICHAEL J SOARES · 1986 to 2026
$10.1M
Anti-Coagulation Factors and PlacentationR01HD099638 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SOARES, MICHAEL J · 2019 to 2023
$2.5M
Trophoblast-Guided Uterine Transformation in the Establishment of PregnancyR01HD105734 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI MICHAEL J SOARES · 2022 to 2026
$2.2M
Mapping causal genetic processes in non-Mendelian pediatric rare diseaseR35GM146966 · NIGMS · CHILDREN'S MERCY HOSP (KANSAS CITY, MO) · PI Craig Smail · 2022 to 2026
$1.9M
Regulation of Invasive Trophoblast Cell Lineage DevelopmentR00HD107262 · NICHD · CHILDREN'S MERCY HOSP (KANSAS CITY, MO) · PI VARBERG, KAELA MARGARET · 2023 to 2025
$740k
Novel computational approaches to characterize the effects of rare functional outlier variants on cis- and trans-regulatory disease processesR21HG012422 · NHGRI · CHILDREN'S MERCY HOSP (KANSAS CITY, MO) · PI SMAIL, CRAIG · 2022 to 2023
$429k
Supplement (Covid) to Regulation of endovascular trophoblast cell development and uterine spiral artery remodelingF32HD096809 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI VARBERG, KAELA MARGARET · 2018 to 2021
$232k
Regulation of Invasive Trophoblast Cell Lineage DevelopmentK99HD107262 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI VARBERG, KAELA MARGARET · 2022 to 2023
$142k
NHGRI NIH HHS R21 HG012422NICHD NIH HHS F32 HD096809NICHD NIH HHS K99 HD107262NICHD NIH HHS R00 HD107262NICHD NIH HHS R01 HD020676NICHD NIH HHS R01 HD099638NICHD NIH HHS R01 HD105734NIGMS NIH HHS R35 GM146966
6 · The paper itself

Abstract

The extravillous trophoblast cell lineage is a key feature of placentation and successful pregnancy. Knowledge of transcriptional regulation driving extravillous trophoblast cell development is limited. Here, we map the transcriptome and epigenome landscape as well as chromatin interactions of human trophoblast stem cells and their transition into extravillous trophoblast cells. We show that integrating chromatin accessibility, long-range chromatin interactions, transcriptomic, and transcription factor binding motif enrichment enables identification of transcription factors and regulatory mechanisms critical for extravillous trophoblast cell development. We elucidate functional roles for TFAP2C, SNAI1, and EPAS1 in the regulation of extravillous trophoblast cell development. EPAS1 is identified as an upstream regulator of key extravillous trophoblast cell transcription factors, including ASCL2 and SNAI1 and together with its target genes, is linked to pregnancy loss and birth weight. Collectively, we reveal activation of a dynamic regulatory network and provide a framework for understanding extravillous trophoblast cell specification in trophoblast cell lineage development and human placentation.

Indexed as

ChromatinTrophoblastsBasic Helix-Loop-Helix ProteinsCell DifferentiationCell LineageFemaleHumansPlacentaPlacentationPregnancyTranscription FactorsASCL2 protein, humanBasic Helix-Loop-Helix ProteinsChromatinTranscription Factors

Identifiers

PMID37563143
PMCPMC10415281
OpenAlexW4385724591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.